We are live on ! Find out more
HALO icon

Halozyme

342 hedge funds and large institutions have $5.81B invested in Halozyme in 2020 Q4 according to their latest regulatory filings, with 100 funds opening new positions, 105 increasing their positions, 107 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 100 | Existing positions closed: 25

285% more call options, than puts

Call options by funds: $22.8M | Put options by funds: $5.93M

65% more capital invested

Capital invested by funds: $3.53B → $5.81B (+$2.28B)

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

28% more funds holding

Funds holding: 268342 (+74)

2.98% more ownership

Funds ownership: 97.87%100.85% (+3%)

2% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 107

Holders
342
Holders Change
+74
Holders Change %
+27.61%
% of All Funds
6.05%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
100
Increased
105
Reduced
107
Closed
25
Calls
$22.8M
Puts
$5.93M
Net Calls
+$16.9M
Net Calls Change
-$129K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$789M +$190M +5,272,072 +40%
Vanguard Group
2
Vanguard Group
Pennsylvania
$562M +$15.2M +422,287 +3%
Artisan Partners
3
Artisan Partners
Wisconsin
$439M -$188M -5,233,788 -34%
William Blair Investment Management
4
William Blair Investment Management
Illinois
$272M -$5.69M -158,182 -2%
State Street
5
State Street
Massachusetts
$236M +$34.9M +970,399 +21%
Invesco
6
Invesco
Georgia
$228M +$39.1M +1,086,911 +26%
JP Morgan Chase
7
JP Morgan Chase
New York
$222M +$8.35M +232,383 +5%
BG
8
Bellevue Group
Switzerland
$173M -$51.2M -1,424,131 -26%
SCM
9
Snyder Capital Management
California
$141M -$2.87M -79,926 -2%
Goldman Sachs
10
Goldman Sachs
New York
$113M +$3.28M +91,332 +4%
FLAM
11
First Light Asset Management
Minnesota
$110M +$23.9M +665,103 +35%
Macquarie Group
12
Macquarie Group
Australia
$99M +$6.17M +171,548 +8%
Northern Trust
13
Northern Trust
Illinois
$95.8M +$8.47M +235,691 +12%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$90.9M +$3.05M +84,776 +4%
Loomis, Sayles & Company
15
Loomis, Sayles & Company
Massachusetts
$84.8M +$19.3M +538,171 +37%
EAM
16
Eagle Asset Management
Florida
$79.5M -$9.99M -278,015 -13%
TS
17
Third Security
Virginia
$75.3M -$44.1M -1,226,460 -41%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$73.3M -$27.2M -757,890 -31%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$69M +$27.3M +759,894 +89%
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$68.2M -$2.31M -64,274 -4%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$62.9M +$27.1M +753,065 +105%
CTA
22
Carillon Tower Advisers
Florida
$56.2M -$2.38M -66,303 -5%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$55.3M -$38.8M -1,078,709 -45%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$53.2M +$42.5M +1,183,456 +1,870%
Thrivent Financial for Lutherans
25
Thrivent Financial for Lutherans
Minnesota
$53.2M +$2.04M +56,814 +5%

HALO Hedge Fund Activity: Q4 2020 in Review

342 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2020, worth a combined $5.81B — up 65% from $3.53B a quarter earlier.

Buyers outnumbered sellers: 100 funds opened new HALO positions and 25 closed out — a net gain of 75 holders — while 105 added to existing stakes and 107 trimmed.

The largest buyer was BlackRock, adding an estimated $190M. The largest seller was Artisan Partners, cutting an estimated $188M.

  • 342 institutional investors held Halozyme (HALO) as of Q4 2020, up from 268 in Q3 2020.
  • Funds reported $5.81B of Halozyme stock for Q4 2020, up 65% quarter-over-quarter.
  • 100 funds opened new Halozyme positions in Q4 2020 and 25 closed out, a net change of +75 holders.
  • The largest Halozyme buyer in Q4 2020 was BlackRock, an estimated $190M added.
  • The largest Halozyme seller in Q4 2020 was Artisan Partners, an estimated $188M sold.

Based on aggregated 13F filings for Q4 2020.